Arzneimittelwerk Warngau
Warngau
About Arzneimittelwerk Warngau
Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $44.7M
- Funding stage: M&A
- Last round: Secondary Market (Mar 2026)
- Website: a-m-w.eu
- Phone: +4980244709990
Industries & Categories
Emergency Medicine, Health Care, Health Diagnostics, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/arzneimittelwerk-warngau-115706 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.